tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
- русский язык имя
- английское имяtert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
- CAS №1651214-74-2
- CBNumberCB43059708
- ФормулаC29H37N7O4
- мольный вес547.65
- файл Mol1651214-74-2.mol
химическое свойство
| Температура кипения | 746.4±70.0 °C(Predicted) |
| плотность | 1.294±0.06 g/cm3(Predicted) |
| пка | 5.24±0.10(Predicted) |
| FDA UNII | CBC6ZM9VNH |
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate химические свойства, назначение, производство
Использование
N-Boc Palbociclib is a protected Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate поставщик
| поставщик | телефон | страна | номенклатура продукции | благоприятные условия |
|---|---|---|---|---|
| 86-714-3992388 | United States | 14336 | 58 | |
| +1-631-485-4226 | United States | 19553 | 58 | |
| 86-571-88216897,88216896 13588875226 |
CHINA | 6313 | 58 | |
| +8615255079626 | China | 23556 | 58 | |
| 571-86758373 +8613588754946 |
CHINA | 3149 | 58 | |
| +8615391658522 | China | 11927 | 58 | |
| +86-021-60753300 | China | 220 | 58 | |
| 571-89925085 | China | 131980 | 58 | |
| 021-58123769 18678586262 |
China | 1354 | 58 | |
| 60753300-53010 13671599112 |
China | 97 | 58 |